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Introduction
Periodontal therapy aims at removal of hard and soft deposits from the root surface. 1 Hand and ultrasonic instrumentation for scaling and root planing (SRP) have shown to be effective approaches for nonsurgical periodontal therapy. 2 Lasers have been suggested as a new alternative for treatment of periodontal disease. 3 Diode laser, neodymium-doped: yttrium, aluminum and garnet laser (Nd:YAG), erbium-doped: yttrium, aluminum and garnet laser (Er:YAG) and carbon dioxide (CO2) laser 4 with wavelengths (λ) ranging from 630 nm to 10600 nm are commonly used for periodontal therapy. Lasers have been considerably used due to their antibacterial potential by direct ablation, thermal denaturation, and destruction of bacterial cells. Photodynamic therapy (PDT) combines the use of visible light and a photo sensitizer, to produce singlet oxygen molecules and free radicals which have an antimicrobial effect. 5 The use of helium/neon (He/Ne) laser or gallium-aluminium arsenide (GaAlAs) laser with a suitable photo sensitizer showed a significant reduction of bacteria in subgingival plaque from subjects with chronic periodontitis. 6 Bacteria associated with periodontal disease can also be killed through photosensitization using toluidine blue O with He/Ne laser. 7 A positive effect on pocket depth reduction as well as improvement in clinical levels and bleeding on probing (BOP) have also been reported. 8, 9 Lui et al showed a beneficial effect when they combined photodynamic and low level laser therapy in nonsurgical treatment of chronic periodontitis. 10 Periodontitis is a disease with multi factorial etiology causing the destruction of supporting structures resulting in formation of periodontal pocket and loss of alveolar bone. 11 The major determinant of this disease susceptibility is the host immune inflammatory response to the subgingival biofilm. The pathogenesis of periodontitis involves role play of cytokines, produced by host defense cells in reaction to antigenic stimuli, which have a wide range of overlapping functions. These cytokines are soluble proteins that paradoxically result in maximum tissue damage leading to the clinical manifestation of the disease. Interleukin-17 (IL-17) is one such pro-inflammatory cytokine that is involved in causing loss of alveolar bone in periodontitis. 12 This cytokine is produced by activated CD4 + T cells 13, 14 and neutrophils. 15, 16 IL-17 expression
As limited data exist on combined therapy of laser and PDT in the treatment of patients with periodontitis, this study aims to compare the efficacy of combination therapy of diode laser and PDT as an adjunct to SRP in the treatment of chronic periodontitis and use the above described IL-17 marker as a diagnostic indicator of disease regression.
Methods

Subjects
Thirty Indian adults (19 males and 11 females with a mean age of 38.03 years) were recruited from the Mahatma Gandhi Mission's Dental College and Hospital, Navi Mumbai. Inclusion criteria were (i) subjects aged 30-49 years, (ii) dentition with at least 20 functional teeth, and (iii) subjects with chronic periodontitis having more than two nonadjacent sites with probing pocket depth (PPD) >5 mm, interproximal attachment loss of >3 mm and radiographic evidence of alveolar bone loss. Exclusion criteria were (i) subjects with diabetes mellitus, rheumatoid arthritis, irritable bowel disease, pulmonary disease, multiple sclerosis, bacterial, viral and fungal infections, (ii) subjects who have received any form of periodontal therapy within the past 6 months, (iii) subjects with aggressive periodontitis, (iv) subjects who have received antibiotic therapy within the past 6 months, (v) subjects on anti-inflammatory drug regimen during the past 6 months, (vi) the presence of pulpal or periapical involvement on qualifying teeth, (vii) subjects who have received orthodontic treatment in the past 6 months, (viii) pregnant and lactating women, (ix) physically and mentally challenged subjects, and (x) Smokers. All subjects were informed about the study and gave their consent for the study.
Study Design and Periodontal Examination
The present study was a split mouth double blinded, prospective cohort, and randomized controlled clinical trial.
An experienced clinician (MR) who was blinded to the study procedure collected all clinical data at the baseline and during follow-up visits while another experienced periodontist carried out the desired treatment procedures. Ten patients with probing depth (PD) >5 mm on >1 aspect of each tooth, who were not included in the study were recruited for calibration of the main examiner (MR). The examiner recorded full-mouth PDs at six sites per tooth (excluding the third molars) in two different sessions on these subjects, using a UNC-15 probe. Upon completion of all measurements, the intraexaminer repeatability for PD measurement was assessed. Calibration was accepted if the measured parameters at two appointments were similar at a >90% level. At the initial visit all subjects underwent full-mouth periodontal examination and based on the inclusion criteria, teeth were randomly allocated to the test group (SRP plus combined therapy using diode laser and PDT) or control group (SRP alone). The subjects then received one stage full mouth SRP under local anesthesia (2% lignocaine with 1:80 000 adrenaline) using ultrasonic scaler (Satelec, Suprasson Newron, France) and/or Gracey curettes (Hu-Friedy #1-14, USA) and routine oral hygiene instructions. Full mouth alginate impressions were made and poured in dental stone to make the diagnostic cast on which customized acrylic stents was fabricated. These stents were used to assure reproducible measuring points for PPD and relative attachment levels (RALs). The patients were recalled after 1 week for collection of GCF to assess the levels of IL-17, which was recorded as our baseline data. Clinical parameters namely PD, RAL, BOP and gingival index (GI) were also recorded. After removal of supragingival plaque, therapy using diode laser and PDT was performed for the test teeth. GCF samples were again collected after 3 months to assess the levels of IL-17. Clinical parameters were recorded at 1 month and 3 months respectively ( Figure 1 ).
Gingival Crevicular Fluid Sampling and Assay
Supragingival plaque was removed and teeth were isolated using cotton rolls, microcapillary pipette was used for collection of GCF by placing it extra crevicular at the entrance of the gingival sulcus. Blood-contaminated sam-
The subjects then received one stage full mouth SRP under local anesthesia (2% lignocaine with 1:80000 adrenaline) using ultrasonic scaler (Satelec, Suprasson Newron, France) and/or Gracey curettes (Hu-Friedy #1-14, USA) and routine oral hygiene instructions. Full mouth alginate impressions were made and poured in dental stone to make the diagnostic cast on which customized acrylic stents was fabricated. These stents were used to assure reproducible measuring points for PPD and relative attachment levels (RALs). The patients were recalled after 1 week for collection of GCF to assess the levels of IL-17, which was recorded as our baseline data. Clinical parameters namely PD, RAL, BOP and gingival index (GI) were also recorded.
After removal of supragingival plaque, therapy using diode laser and PDT was performed for the test teeth. GCF samples were again collected after 3 months to assess the levels of IL-17.
Clinical parameters were recorded at 1 month and 3 months respectively ( Figure 1 ).
Supragingival plaque was removed and teeth were isolated using cotton rolls, microcapillary pipette was used for collection of GCF by placing it extra crevicular at the entrance of the ples were discarded. Five microliters of GCF was collected from each site, placed in 100 µL of sterile phosphate buffered saline (pH 7.2) in Eppendorf tubes. The samples were stored at -70ºC. IL-17 was analyzed using an ELI-SA kit (Human IL-17A (homodimer) ELISA Ready-SETGo! ® From eBioscience), and values were presented as pg/µL.
Recording of Clinical Parameters PD was measured at six sites per tooth i.e., mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual and distolingual, from the gingival margin to the base of the gingival pocket using a UNC-15 probe (Hu-Friedy, USA). RAL was measured as the distance from a fixed reference point (FRP) on the customized acrylic stent to the base of the pocket with a UNC-15 probe. BOP was recorded using Ainamo and Bay index (1975) and GI by Loe and Silness (1963).
Adjunctive Laser Treatments After collection of GCF and recording of clinical parameters, the test teeth underwent therapy using diode laser and PDT. Topical anesthetic gel (2% lignocaine Hydrochloride, Neon Laboratories Limited, India) was applied around the concerned teeth and then washed off after 5 minutes with the help of sterile saline. The test teeth first underwent laser therapy using 810 nm diode laser (The Picasso diode laser, AMD Lasers, USA). The laser beam was delivered into the periodontal pocket using a 400 µm fiber optic tip in contact mode from apical to coronal direction using a sweeping motion for 1 minute using 1 W as a continuous wave. 22 Thermal injury was minimized by keeping the tip in constant motion throughout the procedure. Also, diode laser (λ = 810 nm) has a low tissue penetration allowing complete removal of the gingival epithelium with minimal damage to lamina propria. 23 Following which, the same teeth underwent PDT. The periodontal pocket was flooded with 2 mL of 1% methylene blue (S D Fine-Chem Limited, India) from the apical to coronal end of the pocket with the help of a blunt cannula. Three minutes later, the pocket was thoroughly rinsed with saline to remove excess photosensitizer. Following this, an 810 nm diode laser was operated at 0.1 W using a 400 µm fiber optic tip as a continuous wave. The tip was introduced in contact mode at the base of the periodontal pocket from where it was moved in coronal direction using sweeping motion for 1 minute followed by additional vertical movements in apical and coronal directions for 30 seconds. The laser therapy was performed by an experienced periodontist who was not involved in the periodontal examination and data collection. The patient, operator, and dental assistant used safety glasses for protection of the eyes from the laser beam. The laser therapy was carried out in a closed operatory room, with a warning sign at the door to inform those outside.
Statistical Analysis
The distributions of the parameters were checked for normality using the one-sample Kolmogorov-Smirnov test. Because not all data were normally distributed, a decision was taken to use non-parametric tests. To test the mean equality of the two groups with respect to IL-17 level in GCF and the clinical parameters, Kruskal-Wallis was carried out at 5% level of significance. To compare the changes in the IL-17 level in GCF, PD, RAL, BOP, GI at 3 time intervals within test and control groups, Wilcoxon signed rank test was performed. Pair wise comparison of groups at various time intervals was done using Mann-Whitney U test. Differences were considered as statistically significant at P < 0.05. The statistical analysis was done using SPSS software (SPSS for Windows, release 16.0; SPSS Inc., Chicago, IL, USA).
Results
Thirty patients (19 males and 11 females, mean age 38.03) participated in the study. There were no dropouts in the study. Overall, 60 sites (30 test and 30 control) were evaluated for IL-17 levels in GCF. The results for IL-17levels in GCF for both groups at baseline and 3 months are presented in Table 1 and Figure 2 . A significant reduction in IL-17 level was seen in both test and control groups 3 months after the treatment (P < 0.05). However, when comparing both groups no statistically significant difference was seen. The PPD and RAL results (mean ± SD) for both groups at baseline, 1 month and 3 months are presented in Table 2 . Throughout the study a significant reduction of the PD and a significant gain of RAL took place in both groups (P < 0.05; Table 2 , Figures 3 and 4) . However, no statistical significant difference was seen when comparing both groups at 3 time intervals i.e., baseline, 1 month and 3 Table 2) . The BOP and GI results (mean + SD) for both groups at baseline, 1 month and 3 months are presented in Table 3 , Figures 5, and 6 . A significant reduction in BOP and the GI was seen in both groups after 1 month and 3 months of therapy. However the best reduction in BOP and GI was seen in test group as compared to control group and it reached statistical significance (P < 0.05; Table 3 ).
Discussion
In the present study, we used combination therapy of diode laser and PDT as an adjunct to SRP. Diode laser helps to reduce subgingival microbiota thus providing sites for new connective tissue attachment. 24 It also helps in the promotion of hemostasis, has detoxifying effects and enhances healing. In addition, PDT using methylene blue dye exerts antimicrobial effect, by allowing methylene blue to enter gram-negative bacteria through the porin-protein channels of the outer membrane which upon activation using diode laser, releases oxidizing metabolites that have harmful effects on lipopolysaccharide.
25
Th1/Th2 paradigm has an important role in the host immune defense responses in chronic periodontitis. 26 However with the discovery of Th17 cells and Th17-related cytokines, pathogenesis of periodontitis has seen a new trend. We analyzed GCF levels of IL-17, at baseline and 3 months after the completion of treatment. IL-17 is a pro-inflammatory cytokine that is involved in causing an alveolar bone loss in periodontitis. Vernal et al reported high levels of IL-17 in GCF and in the culture supernatants of gingival cells of patients with periodontitis. 18 Takahashi et al also suggested an important role of IL-17 in the pathogenesis of periodontal disease. 21 We also Gingival Index
Test Control reported a significant increase in levels of IL-17 in GCF in patients with chronic periodontitis. On the contrary a study by Pradeep et al found no significant relationship between IL-17 and periodontitis. 27 In our study, we found a statistical significant reductions in levels of IL-17 in both treatment groups 3 months after treatment, however when comparing both treatment modalities no significant difference was found. This change in levels of IL-17 after treatment is in accordance with various other studies which also reported significant reductions in levels of IL-17 following treatment. Giannopoulou et al found statistically significant reductions in levels of IL-17 after nonsurgical periodontal therapy with SRP, lasers and PDT. 22 Zhao et al.also found statistically significant reductions in levels of IL-17 after SRP. 19 Shirmohammadi et al also found statistically significant reductions in levels of IL-17 after one stage full mouth disinfection and SRP. 20 Our study results also showed statistically significant reductions in PDs and RALs in both test and control groups at 1 month and 3 months intervals. When comparing the test and control groups, no statistically significant results were found in respect to PDs reductions and RALs gains. This is in accordance with various studies where no statistically significant difference in reduction in PDs and gain in attachment levels were seen in the test group when compared to control groups after an additional treatment using PDT. 10, [28] [29] [30] [31] However our results are not in keeping with a number of recent clinical investigations, which yielded significantly better clinical results for SRP in conjunction with adjunctive PDT than for SRP alone. 8, 9, 32 Test teeth showed a significantly greater reduction in the percentage of sites with BOP compared with control teeth at 1 month and 3 months after treatment. Similar results were obtained by Lui et al when they combined low level laser therapy and PDT. 10 This is in accordance with various other studies which also reported significant greater reductions in BOP after adjunctive use of PDT. 9, 29, 30, 32 Moritz et al showed a significant reduction in bacteria and inflammation when he combined diode laser therapy with SRP. 24 This is in contrast to various other studies which failed to note significant greater improvements after adjunctive use of PDT. 22, 28 Another notable effect was the statistically significant reduction in GI in the test group after one month and three months. Similar changes in GI were reported by de Oliveira et al and Yilmaz et al after PDT as compared to SRP. 31, 33 On the basis of our results, we suggest that reduction in IL-17 levels of GCF after combined therapy using diode laser and PDT or SRP corresponds to the clinical improvements seen in the periodontal status and it can be used as a potential marker of periodontal disease activity. Further use of combined therapy with diode laser and PDT may provide additional benefit as they may help in reduction of key virulence factors such as lipopolysaccharide and proteases. 34 However, at present there is no established protocol for use of lasers as an adjunct to SRP. Therefore, more studies are required to establish an effective treatment protocol of the combination of this treatment modality in the treatment of patients with chronic periodontitis.
Conclusion
The results show that, both treatment modalities resulted in significant decrease in level of IL-17 in GCF in patients with chronic periodontitis suggesting the efficacy of combination therapy of diode laser and PDT as an adjunct to SRP on reducing levels of IL-17 in GCF in patients with chronic periodontitis.
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